Discover how a flexible bioanalytical strategy enabled rapid PK and PD biomarker data delivery for a complex global clinical trial.

Time-sensitive clinical programs require more than scientific expertise. They also demand operational flexibility, rapid turnaround, and seamless coordination. This case study highlights how Eurofins Viracor BioPharma implemented a responsive bioanalytical model to support a global Phase II/III clinical trial, delivering critical PK and PD biomarker data with minimal advance notice while maintaining quality and regulatory-ready data standards.

Key highlights include:

• Support of a global Phase II/III clinical trial for a rare, life-threatening inflammatory syndrome
• Rapid delivery of PK and PD biomarker data to support treatment monitoring and clinical decision-making
• Implementation of second-shift laboratory coverage and continuous readiness to accommodate sample shipments with as little as 24 hours' notice
• Development of a trained analyst network to provide flexible, scalable testing support
• Proactive communication, risk assessment, and project oversight to reduce delays and operational risk
• Standardized CDISC-compliant data delivery to support regulatory requirements

This case study demonstrates how bioanalytical expertise, operational agility, and proactive project management can help sponsors meet demanding clinical trial timelines and deliver critical data when timing matters most.